-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Eiger BioPharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
- Eiger BioPharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $2K.
- Eiger BioPharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $6K, a 73.9% decline year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $6K, a 73.9% decline from 2022.
- Eiger BioPharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $23K, a 64.1% decline from 2021.
- Eiger BioPharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $64K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)